Search for: "Marketing King, Inc." Results 1 - 20 of 881
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Aug 2010, 9:57 pm by Patent Docs
By Andrew Williams -- Last week, in King Pharmaceuticals, Inc. v. [read post]
25 Nov 2008, 5:01 am
By Jason Derry -- King Pharmaceuticals, Inc. has announced that it will purchase Alpharma Inc. for about $1.6 billion in cash. [read post]
1 Oct 2008, 2:24 pm
Direct Marketing Concepts, Inc., et. al, the FTC obtained summary judgment against the marketers and its supporting firms relating to disease treatment, and weight loss infomercials, "Coral Calcium" and " Supreme Greens". [read post]
20 Apr 2010, 12:59 pm by Jed
  By this action, the Court is basically going to revisit its earlier decision in Quality King Distributors, Inc. v. [read post]
28 Dec 2009, 5:29 pm
By Eric Goldman King Pharmaceuticals, Inc., v ZymoGenetics, Inc., 2009 WL 4931238 (E.D. [read post]
8 Mar 2011, 3:56 pm
District Court for the Western District of Washington says that King County, Washington has pleaded sufficient facts to continue with its securities fraud lawsuit accusing Merrill Lynch, Merrill Lynch, Pierce, Fenner and Smith Inc. and Merrill Lynch Money Markets Inc. of facilitating its purchase of allegedly toxic mortgage-backed securities and violating the Washington State Securities Act. [read post]
29 Jan 2007, 9:21 pm
King County Superior Court has granted Texas-based Detex Corp. summary judgment imposing a permanent injunction over Israel-based Detex Security Systems, Inc. [read post]
30 Nov 2023, 9:00 am by luiza
That was the case in the King Kong matter with King Kong’s competitor, China Pacificarbide, Inc., filing the original False Claims Act case that initiated the government’s investigation and ultimate settlement. [read post]
17 Jan 2011, 3:10 pm by Margaret Grisdela
As we celebrate the Martin Luther King holiday, it is an appropriate time to consider the role of diversity in legal marketing. [read post]
25 Jan 2010, 5:00 am by Beck, et al.
Conversely, if plaintiffs could import the “fraud on the market” presumption of reliance into non-securities contexts – such as consumer fraud/common-law fraud/warranty litigation against our drug/device clients – an invasion of class actions would follow like night follows day.It’s hardly surprising that, because we don’t want class actions certified against our clients, we’re not big fans of “fraud on the market,” and we want… [read post]